国外制药企业环保监管及其对我国的启示

发布时间：2018-07-12 16:34

本文选题：制药企业 + 环保制度　；参考：《郑州大学》2014年硕士论文

【摘要】：目前，我国城镇化、工业化得到快速发展，经济发展的同时也带来了一些不良后果，资源匮乏、能源紧缺、环境压力加大已成为制约中国现代化的关键性因素，节约资源和保护环境已成为实现可持续发展的根本诉求。随着十八大“美丽中国”和包括生态文明建设在内的“五位一体”总布局的提出，生态文明建设成为中国特色社会主义发展道路的必然选择和创新举措。本文基于这样的背景，对我国制药行业的环境问题进行了初步研究。主要涉及两个方面：一是制药企业环境保护制度；二是上市制药企业环境信息披露制度和情况。在研究的视角上主要采用中外对比的视角，以美国、欧盟、日本等发达国家在这两方面的做法作为对照，来考察我国的现状，从而找出差距，总结适合我国国情和行业发展现状的借鉴之处，提出完善我国制药行业环境保护制度和上市制药企业环境信息披露制度以及披露水平的建议。在研究方法上采用了文献研究、比较分析和综合归纳法。文章主要分为以下四个章节：第一章为绪论，主要阐明本文的选题背景、研究意义和现状评述；第二章探讨国外制药企业环保制度及对我国的借鉴意义。介绍了发达国家先进的制药企业环保制度和政策，并与我国的制药企业环保制度进行对比，从而找出差距，提出了完善我国制药企业环境保护制度的若干建议。第三章关注国内外上市药企的环境信息披露。先介绍了国内以及美国、日本等发达国家上市公司环境信息披露制度情况，然后以我国沪深股市上市的157家主营业务涉及制药的上市企业为样本，分析了国内制药企业环境信息披露的现状；随后以3家国外世界五百强上市药企为样本，进行了国外制药企业环境信息披露的案例分析。最后进行了国内外的对比，提出了完善我国上市制药企业环境信息披露的建议。第四章是结论部分，，对文章得出的结论进行了总结。
[Abstract]:At present, the rapid development of urbanization and industrialization in our country has brought some adverse consequences along with economic development. The scarcity of resources, the shortage of energy and the increasing environmental pressure have become the key factors restricting China's modernization. Conservation of resources and protection of the environment has become a fundamental demand for sustainable development. With the proposal of the "beautiful China" and the general layout of "five in one" including the construction of ecological civilization, the construction of ecological civilization has become an inevitable choice and innovative measure for the development of socialism with Chinese characteristics. Based on this background, this paper makes a preliminary study on the environmental problems of pharmaceutical industry in China. It mainly involves two aspects: one is the environmental protection system of pharmaceutical enterprises, the other is the environmental information disclosure system and situation of listed pharmaceutical enterprises. In the perspective of research, we mainly adopt the perspective of comparison between China and foreign countries, and compare the practices of the developed countries such as the United States, the European Union, Japan and other developed countries in these two aspects, to examine the current situation of our country, and thus to find out the gap. In this paper, the author sums up the reference points suitable for China's national conditions and industry development, and puts forward some suggestions for perfecting the environmental protection system of pharmaceutical industry and the environmental information disclosure system of listed pharmaceutical enterprises as well as the level of disclosure. Literature research, comparative analysis and comprehensive induction are used in the research methods. The article is divided into the following four chapters: the first chapter is the introduction, mainly expounds the background of this topic, research significance and current situation review; the second chapter discusses the environmental protection system of foreign pharmaceutical enterprises and the significance of reference to our country. This paper introduces the advanced environmental protection systems and policies of pharmaceutical enterprises in developed countries, compares them with those of our country, finds out the gap, and puts forward some suggestions for perfecting the environmental protection system of pharmaceutical enterprises in China. The third chapter focuses on the environmental information disclosure of listed pharmaceutical companies at home and abroad. This paper first introduces the environmental information disclosure system of listed companies in China, as well as developed countries such as the United States and Japan, and then takes 157 listed companies whose main businesses are involved in pharmaceutical companies listed in China's Shanghai and Shenzhen stock markets as samples. The current situation of environmental information disclosure in domestic pharmaceutical enterprises is analyzed, and then the case study of environmental information disclosure of foreign pharmaceutical enterprises is carried out by taking three listed pharmaceutical companies in the world as samples. Finally, the author makes a comparison at home and abroad, and puts forward some suggestions for perfecting the environmental information disclosure of listed pharmaceutical enterprises in China. The fourth chapter is the conclusion part, the conclusion of the article is summarized.
【学位授予单位】：郑州大学
【学位级别】：硕士
【学位授予年份】：2014
【分类号】：F416.72;F205

【参考文献】